Spiegelman Daniel K (CIK 0001238403)

Latest company ownership

Shares held
47,686
Last filed at
Jun 7, 2019
Confidence Score
50.0
2025Q4
Confidence Score History
2016Q2 2025Q4
Shares held
32,917
Last filed at
Jun 7, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jun 3, 2024 Jun 4, 2024 MYRIAD GENETICS INC Director Sell 20.0 -7,576 -18.71% ✓ $167K
Jun 1, 2023 Jun 2, 2023 MYRIAD GENETICS INC Director Sell 95.0 +6,513 19.17% ✓ $198.8K
Jun 6, 2022 Jun 6, 2022 MYRIAD GENETICS INC Director Sell 20.0 -6,424 -15.90% ✓ $123.7K
Jun 17, 2021 Jun 17, 2021 MYRIAD GENETICS INC Director Sell 25.0 -3,139 -11.95% ✓ $95.8K
May 28, 2021 Jun 1, 2021 MYRIAD GENETICS INC Director Sell 10.0 -7,142 -34.73% ✓ $207K
Apr 1, 2019 Apr 3, 2019 BIOMARIN PHARMACEUTICAL INC CFO Sell 10.0 -13,473 -22.09% ✓ $1.2M
Mar 27, 2019 Mar 29, 2019 BIOMARIN PHARMACEUTICAL INC CFO Sell 55.0 -100 -0.16% ✓ $9K
Mar 22, 2019 Mar 26, 2019 BIOMARIN PHARMACEUTICAL INC CFO Sell 20.0 -3,598 -5.56% ✗ $316.8K
Mar 15, 2019 Mar 19, 2019 BIOMARIN PHARMACEUTICAL INC CFO Sell 90.0 +2,143 3.43% ✗ $683.2K
Mar 1, 2019 Mar 5, 2019 BIOMARIN PHARMACEUTICAL INC CFO Sell 95.0 +11,293 22.04% ✗ $86.4K
Jun 22, 2018 Jun 26, 2018 BIOMARIN PHARMACEUTICAL INC CFO Sell 17.5 -10,000 -16.37% ✓ $990K
Apr 30, 2018 Jun 6, 2018 BIOMARIN PHARMACEUTICAL INC CFO Sell 22.5 -1,544 -2.47% ✗ $157.5K
Mar 22, 2018 Apr 27, 2018 BIOMARIN PHARMACEUTICAL INC CFO Sell 20.0 -3,598 -4.66% ✗ $292.7K
Apr 23, 2018 Apr 25, 2018 BIOMARIN PHARMACEUTICAL INC CFO Sell 17.5 -11,059 -15.03% ✓ $908.5K
Mar 22, 2018 Mar 26, 2018 BIOMARIN PHARMACEUTICAL INC CFO Sell 20.0 -3,583 -4.64% ✗ $291.5K
Mar 15, 2018 Mar 19, 2018 BIOMARIN PHARMACEUTICAL INC CFO Sell 97.5 +8,665 12.65% ✗ $318.8K
Mar 2, 2018 Mar 6, 2018 BIOMARIN PHARMACEUTICAL INC CFO Sell 22.5 -1,609 -2.29% ✗ $128.5K
May 27, 2015 Oct 13, 2017 BIOMARIN PHARMACEUTICAL INC CFO Sell 5.0 -34,078 -31.08% ✓ $4.4M
Jun 2, 2017 Jun 6, 2017 BIOMARIN PHARMACEUTICAL INC CFO Sell 22.5 -1,801 -7.17% ✗ $163.4K
Apr 28, 2017 May 17, 2017 BIOMARIN PHARMACEUTICAL INC CFO Sell 22.5 -1,567 -5.88% ✗ $157.6K
Mar 15, 2017 Mar 17, 2017 BIOMARIN PHARMACEUTICAL INC CFO Sell 7.5 -6,290 -30.30% ✓ $580.8K
Mar 6, 2017 Mar 8, 2017 BIOMARIN PHARMACEUTICAL INC CFO Sell 28.8 -2,303 -9.99% ✓ $214.9K
Mar 3, 2017 Mar 7, 2017 BIOMARIN PHARMACEUTICAL INC CFO Sell 22.5 -2,283 -9.01% ✗ $214.5K
Feb 28, 2017 Mar 2, 2017 BIOMARIN PHARMACEUTICAL INC CFO Sell 5.0 -35,000 -58.00% ✓ $3.3M
Jan 9, 2017 Jan 10, 2017 BIOMARIN PHARMACEUTICAL INC CFO Sell 12.5 -5,000 -21.65% ✓ $450K
Oct 31, 2016 Nov 14, 2016 BIOMARIN PHARMACEUTICAL INC CFO Sell 17.5 -19,844 -46.21% ✗ $1.8M
Aug 1, 2016 Aug 3, 2016 BIOMARIN PHARMACEUTICAL INC CFO Sell 26.3 -4,000 -8.52% ✓ $397.3K
Jun 6, 2016 Jun 8, 2016 BIOMARIN PHARMACEUTICAL INC CFO Sell 37.5 -1,649 -3.39% ✓ $147K
Jun 3, 2016 Jun 7, 2016 BIOMARIN PHARMACEUTICAL INC CFO Sell 22.5 -1,801 -3.57% ✗ $162.1K
May 31, 2016 Jun 2, 2016 BIOMARIN PHARMACEUTICAL INC CFO Sell 5.0 -20,841 -29.26% ✓ $1.9M
May 27, 2016 May 31, 2016 BIOMARIN PHARMACEUTICAL INC CFO Sell 20.0 -4,305 -7.34% ✗ $383.5K
May 23, 2016 May 25, 2016 BIOMARIN PHARMACEUTICAL INC CFO Sell 30.0 -3,769 -6.04% ✓ $328.2K
Apr 29, 2016 May 17, 2016 BIOMARIN PHARMACEUTICAL INC CFO Sell 22.5 -1,520 -2.38% ✗ $142.4K